Vimarsana
Biggest News Aggregation in the World

However Pfizer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from However Pfizer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In However Pfizer Today - Breaking & Trending Today

Approval for Moderna's vaccine 'looks positive' but a few more documents still needed - Vimarsana News

Approval for Moderna's vaccine 'looks positive' but a few more documents still needed

Approval for Moderna's vaccine 'looks positive' but a few more documents still needed by Mia Rabson, The Canadian Press Posted Dec 15, 2020 4:00 am EDT Last Updated Dec 15, 2020 at 4:14 am EDT OTTAWA — The chief medical adviser at Health Canada says things are on track for her department to approve a second vaccine for COVID-19 very soon. Dr. Supriya Sharma says things “look positive” for the vaccine from U.S. biotech firm Moderna but there are still some outstanding manufacturing documents needed before the decision can be made. Ongoing reviews of two more vaccines are less certain, wi...

Approval for Moderna's vaccine 'looks positive' but a few more documents still needed | 620 CKRM The Source - Vimarsana News

Approval for Moderna's vaccine 'looks positive' but a few more documents still needed | 620 CKRM The Source

By News Room Dec 15, 2020 10:15 AM Prime Minister Justin Trudeau says Canada has signed a contract to receive up to 168,000 doses of Moderna’s COVID-19 vaccine before the end of December. The Moderna vaccine has not yet been approved by Health Canada but Trudeau says deliveries could begin within 48 hours of that happening. The chief medical adviser at Health Canada, Dr. Supriya Sharma, says things “look positive” for the vaccine from the U.S. biotech firm but there are still some outstanding manufacturing documents needed before the decision can be made. She said the r...

Approval for Moderna's vaccine 'looks positive' but a few more documents still needed | iNFOnews - Vimarsana News

Approval for Moderna's vaccine 'looks positive' but a few more documents still needed | iNFOnews

Christopher Reynolds and Mia Rabson A syringe of the COVID-19 vaccine waits to be administered in Toronto on Monday, Dec. 14, 2020. THE CANADIAN PRESS/Frank Gunn December 15, 2020 - 5:42 PM OTTAWA - At 8:05 a.m. on a cold, cloudless day, personal support worker Jo-Anne Miner became the first person of 1.4 million in the Ottawa-Gatineau area to receive the COVID-19 vaccine, hours before the federal government announced that hundreds of thousands more doses would arrive in Canada by the end of the year. Frigid boxes holding some of the up to 417,000 vaccine doses set...

Source: infotel.ca
Moderna's vaccine approval 'looks positive' but a few more documents still needed - Vimarsana News

Moderna's vaccine approval 'looks positive' but a few more documents still needed

The chief medical adviser at Health Canada says things are on track for her department to approve a second vaccine for COVID-19 very soon. Dr. Supriya Sharma says things "look positive" for the vaccine from U.S. biotech firm Moderna but there are still some outstanding manufacturing documents needed before the decision can be made. Ongoing reviews of two more vaccines are less certain, with AstraZeneca's potentially needing more study before Health Canada is ready to make a decision, and the Johnson & Johnson vaccine candidate's review still in the very early stages. Get top stories in your i...

Moderna Vaccine Approval in the Works, 'Looks Positive' - Vimarsana News

Moderna Vaccine Approval in the Works, 'Looks Positive'

Moderna Vaccine Approval in the Works, ‘Looks Positive’ OTTAWA—The chief medical adviser at Health Canada says things are on track for her department to approve a second vaccine for COVID-19 very soon. Dr. Supriya Sharma says things “look positive” for the vaccine from U.S. biotech firm Moderna but there are still some outstanding manufacturing documents needed before the decision can be made. Ongoing reviews of two more vaccines are less certain, with AstraZeneca’s potentially needing more study before Health Canada is ready to make a decision, and the Johnson & Johnson vaccine c...